Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

All Conditions

Symptoms and General Pathology

Prostatic Neoplasms

Prostatic Hyperplasia

Hyperplasia

Lower Urinary Tract Symptoms

Genital Neoplasms, Male

Urogenital Neoplasms

Genital Diseases

Genital Diseases, Male

Urogenital Diseases

Prostatic Diseases

Male Urogenital Diseases

The Aquablation therapy is a minimally invasive, image-guided, heat-free robotic therapy delivered by the AQUABEAM Robotic System. During Aquablation therapy, the AQUABEAM Handpiece is inserted transurethrally into the prostatic urethra. The operating physician then utilizes cystoscopy in conjunction with transrectal ultrasound (TRUS) imaging for real time visualization. The AQUABEAM Robotic System utilizes high-velocity sterile saline waterjet to resect and remove the prostate tissue according to the operating physician's treatment plan.

Robotic Waterjet Treatment

Angela Lee

Pooja Talaty, MS MHA CCRP

Jennifer Penshorn, RN

Becky Lau

Aline Yacoubian

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Proportion (percentage) of participants with adverse events rated as related to the study procedure classified as Clavien-Dindo Grade 2 or higher or any Grade 1 event resulting in persistent disability (ejaculatory disorder, erectile dysfunction, or incontinence) evidenced through 3 months post-treatment.

PROCEPT BioRobotics

The Aquablation therapy is a minimally invasive, image-guided, heat-free robotic therapy delivered by the AQUABEAM Robotic System.

During Aquablation therapy, the AQUABEAM Handpiece is inserted transurethrally into the prostatic urethra. The operating physician then utilizes cystoscopy in conjunction with transrectal ultrasound (TRUS) imaging for real-time visualization. The AQUABEAM Robotic System utilizes high-velocity sterile saline waterjet to resect and remove the prostate tissue according to the operating physician's treatment plan.

Daniel Park, DMSc, MHA, PA

Brian Hamblen

Pooja Talaty

Dayna Leis, RN

The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.

PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

The primary endpoint is the proportion (percentage) of participants who experience a serious device-related adverse event within 12 months following the study treatment.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs	NCT06051942	Benign Prostati... Localized Prost...	Robotic Waterje...	- 80 Years	PROCEPT BioRobotics
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System	NCT06054867	Localized Prost...	Robotic Waterje...	40 Years -	PROCEPT BioRobotics

Spots Global Cancer Trial Database for robotic waterjet treatment